Compare DIOD & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIOD | TARS |
|---|---|---|
| Founded | 1959 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 1995 | 2020 |
| Metric | DIOD | TARS |
|---|---|---|
| Price | $71.70 | $77.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $73.50 | ★ $80.56 |
| AVG Volume (30 Days) | 427.5K | ★ 628.4K |
| Earning Date | 05-11-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.53 | 48.21 |
| EPS | ★ 1.43 | N/A |
| Revenue | N/A | ★ $451,360,000.00 |
| Revenue This Year | $15.51 | $51.34 |
| Revenue Next Year | $10.05 | $29.34 |
| P/E Ratio | $47.40 | ★ N/A |
| Revenue Growth | N/A | ★ 146.71 |
| 52 Week Low | $32.93 | $38.51 |
| 52 Week High | $81.71 | $85.25 |
| Indicator | DIOD | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 63.03 | 65.46 |
| Support Level | $46.18 | $77.14 |
| Resistance Level | $81.71 | $84.26 |
| Average True Range (ATR) | 3.86 | 3.90 |
| MACD | -0.14 | 1.87 |
| Stochastic Oscillator | 51.61 | 86.84 |
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.